Early motor dysfunction and striosomal distribution of huntingtin microaggregates in Huntington's disease knock-in mice

Journal of Neuroscience

Volumn 22, Issue 18, 2002, Pages 8266-8276

  Menalled, Liliana B ^a   Sison, Jessica D ^a   Wu, Ying ^a   Olivieri, Melisa ^a   Li, Xiao Jiang ^b   Li, He ^b   Zeitlin, Scott ^c   Chesselet, Marie Françoise ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b EMORY UNIVERSITY   (United States)

^c UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Behavior; CAG repeats; Huntington's disease; Immunohistochemistry; Knock in; Microaggregates; Mouse; Nuclear inclusions; Striatum; Striosomes; opioid receptor

Indexed keywords

ENKEPHALIN; HUNTINGTIN; MESSENGER RNA;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BODY MOVEMENT; BRAIN CORTEX; CELL NUCLEUS INCLUSION BODY; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CORPUS STRIATUM; FEMALE; GENE MUTATION; HUNTINGTON CHOREA; KNOCKIN MOUSE; KNOCKOUT MOUSE; LIFESPAN; LOCOMOTION; MALE; MICROSCOPIC ANATOMY; MOTOR DYSFUNCTION; MOUSE; NERVE CELL; NONHUMAN; NUCLEOTIDE REPEAT; PHENOTYPE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; REARING;

EID: 0037107191     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.22-18-08266.2002     Document Type: Article

References (49)

1. Aronin N, Chase K, Sagar SM, Sharp FR, DiFiglia M (1991) N-methyl-D-aspartate receptor activation in the neostriatum increases c-fos and fos-related antigens selectively in medium-sized neurons. Neuroscience 44:409-420.
2. Bhide PG, Day M, Sapp E, Schwarz C, Sheth A, Kim J, Young AB, Penney J, Golden J, Aronin N, DiFiglia M (1996) Expression of normal and mutant huntingtin in the developing brain. J Neurosci 16:5523-5535.
3. Canales JJ, Graybiel AM (2000) A measure of striatal function predicts motor stereotypy. Nat Neurosci 3:377-383.
4. Chesselet MF, Levine MS (2000) Mouse modules of Huntington's disease. In: Molecular Mechanisms of Neurodegenerative Disease (Chesselet MF, ed), pp 327-346. Totowa, NJ: Humana.
5. Chesselet MF, Weiss L, Wuenschell C, Tobin AJ, Affolter HU (1987) Comparative distribution of mRNAs for glutamic acid decarboxylase, tyrosine hydroxylase, and tachykinins in the basal ganglia: An in situ hybridization study in the rodent brain. J Comp Neurol 262:125-140.
6. Davies SW, Turmaine M, Cozens BA, DiFiglia M, Sharp AH, Ross CA, Scherzinger E, Wanker EE, Mangiarini L, Bates GP (1997) Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation. Cell 90:537-548.
7. Desban M, Kemel ML, Glowinski J, Gauchy C (1993) Spatial organization of patch and matrix compartments in the rat striatum. Neuroscience 57:661-671.
8. DiFiglia M, Sapp E, Chase KO, Davies SW, Bates GP, Vonsattel JP, Aronin N (1997) Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science 277:1990-1993.
9. Ferrante RJ, Kowall NW, Beal MF, Martin JB, Bird ED, Richardson Jr EP (1987) Morphologic and histochemical characteristics of a spared subset of striatal neurons in Huntington's disease. J Neuropathol Exp Neurol 46:12-27.
10. Ferrante RJ, Gutekunst CA, Persichetti F, McNeil SM, Kowall NW, Gusella JF, MacDonald ME, Beal MF, Hersch SM (1997) Heterogeneous topographic and cellular distribution of huntingtin expression in the normal human neostriatum. J Neurosci 17:3052-3063.
11. File SE, Mahal A, Mangiarini L, Bates GP (1998) Striking changes in anxiety in Huntington's disease transgenic mice. Brain Res 805:234-240.
12. Fusco FR, Chen Q, Lamoreaux WJ, Figueredo-Cardenas G, Jiao Y, Coffman JA, Surmeier DJ, Honig MG, Carlock LR, Reiner A (1999) Cellular localization of huntingtin in striatal and cortical neurons in rats: Lack of correlation with neuronal vulnerability in Huntington's disease. J Neurosci 19:1189-1202.
13. Graybiel AM (1995) The basal ganglia. Trends Neurosci 18:60-62.
14. Groves PM, Martone M, Young SJ, Armstrong DM (1988) Three-dimensional pattern of enkephalin-like immunoreactivity in the caudate nucleus of the cat. J Neurosci 8:892-900.
15. Gutekunst CA, Levey AI, Heilman CJ, Whaley WL, Yi H, Nash NR, Rees HD, Madden JJ, Hersch SM (1995) Identification and localization of huntingtin in brain and human lymphoblastoid cell lines with anti-fusion protein antibodies. Proc Natl Acad Sci USA 92:8710-8714.
16. Gutekunst CA, Li SH, Yi H, Mulroy JS, Kuemmerle S, Jones R, Rye D, Ferrante RJ, Hersch SM, Li XJ (1999) Nuclear and neuropil aggregates in Huntington's disease: Relationship to neuropathology. J Neurosci 19:2522-2534.
17. Harper PS (1996) Huntington's Disease. Philadelphia: Saunders.
18. Hedreen JC (1998) Neuronal intranuclear inclusions in neostriatal striosomes and matrix in Huntington's disease. International Basal Ganglia Society Meeting VI, Brewster, MA, October.
19. Hedreen JC, Folstein SE (1995) Early loss of neostriatal striosome neurons in Huntington's disease. J Neuropathol Exp Neurol 54:105-120.
20. Kennedy L, Shelbourne PF (2000) Dramatic mutation instability in HD mouse striatum: Does polyglutamine load contribute to cell-specific vulnerability in Huntington's disease? Hum Mol Genet 9:2539-2544.
21. Kim M, Lee HS, LaForet G, McIntyre C, Martin EJ, Chang P, Kim TW, Williams M, Reddy PH, Tagle D, Boyce FM, Won L, Heller A, Aronin N, DiFiglia M (1999) Mutant huntingtin expression in clonal striatal cells: Dissociation of inclusion formation and neuronal survival by caspase inhibition. J Neurosci 19:964-973.
22. Klapstein GJ, Fisher RS, Zanjani H, Cepeda C, Jokel ES, Chesselet MF, Levine MS (2001) Electrophysiological and morphological changes in striatal spiny neurons in R6/2 Huntington's disease transgenic mice. J Neurophysiol 86:2667-2677.
23. Klement IA, Skinner PJ, Kaytor MD, Yi H, Hersch SM, Clark HB, Zoghbi HY, Orr HT (1998) Ataxin-1 nuclear localization and aggregation: Role in polyglutamine-induced disease in SCA1 transgenic mice. Cell 95:41-53.
24. Kosinski CM, Cha JH, Young AB, Persichetti F, MacDonald M, Gusella JF, Penney Jr JB, Standaert DG (1997) Huntingtin immunoreactivity in the rat neostriatum: Differential accumulation in projection and interneurons. Exp Neurol 144:239-247.
25. Kuemmerle S, Gutekunst CA, Klein AM, Li XJ, Li SH, Beal MF, Hersch SM, Ferrante RJ (1999) Huntington aggregates may not predict neuronal death in Huntington's disease. Ann Neurol 46:842-849.
26. Levine MS, Klapstein GJ, Koppel A, Gruen E, Cepeda C, Vargas ME, Jokel ES, Carpenter EM, Zanjani H, Hurst RS, Efstratiadis A, Zeitlin S, Chesselet MF (1999) Enhanced sensitivity to N-methyl-D-aspartate receptor activation in transgenic and knockin mouse models of Huntington's disease. J Neurosci Res 58:515-532.
27. Luesse HG, Schiefer J, Spruenken A, Puls C, Block F, Kosinski CM (2001) Evaluation of R6/2 HD transgenic mice for therapeutic studies in Huntington's disease: Behavioral testing and impact of diabetes mellitus. Behav Brain Res 126:185-195.
28. Li H, Li SH, Cheng AL, Mangiarini L, Bates GP, Li XJ (1999) Ultrastructural localization and progressive formation of neuropil aggregates in Huntington's disease transgenic mice. Hum Mol Genet 8:1227-1236.
29. Li H, Li SH, Johnston H, Shelbourne PF, Li XJ (2000) Amino-terminal fragments of mutant huntingtin show selective accumulation in striatal neurons and synaptic toxicity. Nat Genet 25:385-389.
30. Lin CH, Tallaksen-Greene S, Chien WM, Cearley JA, Jackson WS, Crouse AB, Ren S, Li XJ, Albin RL, Detloff PJ (2001) Neurological abnormalities in a knock-in mouse model of Huntington's disease. Hum Mol Genet 10:137-144.
31. Mangiarini L, Sathasivam K, Seller M, Cozens B, Harper A, Hetherington C, Lawton M, Trottier Y, Lehrach H, Davies SW, Bates GP (1996) Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell 87:493-506.
32. Menalled L, Chesselet M-F (2001) Mouse models of Huntington's disease. Trends Pharmacol Sci 23:32-39.
33. Menalled L, Zanjani H, MacKenzie L, Koppel A, Carpenter E, Zeitlin S, Chesselet MF (2000) Decrease in striatal enkephalin mRNA in mouse models of Huntington's disease. Exp Neurol 162:328-342.
34. Menalled LB, Sison J, Zeitlin S, Li XJ, Chesselet MF (2001) Temporal and regional development of huntingtin aggregates in a knock-in mouse model of Huntington's disease. Soc Neurosci Abstr 31:325.6.
35. Morton AJ, Lagan MA, Skepper JN, Dunnett SB (2000) Progressive formation of inclusions in the striatum and hippocampus of mice transgenic for the human Huntington's disease mutation. J Neurocytol 29:679-702.
36. Oorschot DE (1996) Total number of neurons in the neostriatal, pallidal, subthalamic, and substantia nigral nuclei of the rat basal ganglia: A stereological study using the Cavalieri and optical dissector methods. J Comp Neurol 366:580-599.
37. Reddy PH, Williams M, Charles V, Garrett L, Pike-Buchanan L, Whetsell Jr WO, Miller G, Tagle DA (1998) Behavioural abnormalities and selective neuronal loss in HD transgenic mice expressing mutated full-length HD cDNA. Nat Genet 20:198-202.
38. Roizin L, Stellar S, Liu JD (1979) Neuronal nuclear-cytoplasmic changes in Huntington chorea: Electron microscope investigations. In: Advances in Neurology: Huntington's Disease (Chase TN, Wexler NS, Barbeau A, eds), pp 95-122. New York: Raven.
39. Sapp E, Schwarz C, Chase K, Bhide PG, Young AB, Penney J, Vonsattel JP, Aronin N, DiFiglia M (1997) Huntingtin localization in brains of normal and Huntington's disease patients. Ann Neurol 42:604-612.
40. Saudou F, Finkbeiner S, Devys D, Greenberg ME (1998) Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions. Cell 95:55-66.
41. Seto-Ohshima A, Emson PC, Lawson E, Mountjoy CQ, Carrasco LH (1988) Loss of matrix calcium-binding protein-containing neurons in Huntington's disease. Lancet 1:1252-1255.
42. Shelbourne PF, Killeen N, Hevner RF, Johnston HM, Tecott L, Lewandoski M, Ennis M, Ramirez L, Li Z, Iannicola C, Littman DR, Myers RM (1999) A Huntington's disease CAG expansion at the murine Hdh locus is unstable and associated with behavioural abnormalities in mice. Hum Mol Genet 8:763-774.
43. Smith MA, Brandt J, Shadmehr R (2000) Motor disorder in Huntington's disease begins as a dysfunction in error feedback control. Nature 403:544-549.
44. The Huntington's Disease Collaborative Research Group (1993) A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 72:971-983.
45. Usdin MT, Shelbourne PF, Myers RM, Madison DV (1999) Impaired synaptic plasticity in mice carrying the Huntington's disease mutation. Hum Mol Genet 8:839-846.
46. van Vugt JP, Siesling S, Piet KK, Zwinderman AH, Middelkoop HA, van Hilten JJ, Roos RA (2001) Quantitative assessment of daytime motor activity provides a responsive measure of functional decline in patients with Huntington's disease. Mov Disord 16:481-488.
47. Vonsattel JP, Myers RH, Stevens TJ, Ferrante RJ, Bird ED, Richardson Jr EP (1985) Neuropathological classification of Huntington's disease. J Neuropathol Exp Neurol 44:559-577.
48. Wheeler VC, White JK, Gutekunst CA, Vrbanac V, Weaver M, Li XJ, Li SH, Yi H, Vonsattel JP, Gusella JF, Hersch S, Auerbach W, Joyner AL, MacDonald ME (2000) Long glutamine tracts cause nuclear localization of a novel form of huntingtin in medium spiny striatal neurons in HdhQ92 and HdhQ111 knock-in mice. Hum Mol Genet 9:503-513.
49. White JK, Auerbach W, Duyao MP, Vonsattel JP, Gusella JF, Joyner AL, MacDonald ME (1997) Huntingtin is required for neurogenesis and is not impaired by the Huntington's disease CAG expansion. Nat Genet 17:404-410.